The LAGE3 gene helps cells make proteins correctly by supporting a key step in reading genetic instructions. When it does not work properly, cells can struggle to grow and function normally, especially in the brain and kidneys. This gene plays an important role in early development, and pathogenic variants can cause a form of Galloway-Mowat syndrome. People with these variants may have developmental delay, a smaller head size, seizures, or kidney disease with protein in the urine.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or guide activities in the body. Some genes provide the information needed to produce proteins, which do much of the cell’s work. Other genes mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
LAGE3Gene function
What if the gene works
The LAGE3 gene helps cells prepare a helper molecule used to build proteins accurately. This supports normal cell growth and everyday function in many tissues.
Risk
What if the gene does not work
Pathogenic variants in the LAGE3 gene cause a form of Galloway-Mowat syndrome, often affecting brain development and kidney function. Milder to more severe variants may influence when features appear and how pronounced they are.
Treatment
What does that mean for your treatment
No LAGE3-specific treatment or drug choice approach is currently established for pathogenic variants in the LAGE3 gene. Care is based on the person’s clinical needs rather than the gene result itself. The LAGE3 gene is also being studied as a possible cancer biomarker in early research.
Conditions associated with LAGE3
Gene function
What if the gene works
Your cells rely on the LAGE3 gene to support accurate protein building. It does this by helping prepare transfer RNA, the small molecules that bring amino acids into place while proteins are made. Understanding the LAGE3 gene’s function helps explain how cells keep this basic step running smoothly each day.
The LAGE3 gene helps add a small chemical tag to transfer RNA, the molecules that carry amino acids during protein building. This tag helps many transfer RNAs work properly when cells read genetic instructions.
By supporting that tag, the LAGE3 gene helps ribosomes, your cells’ protein making machines, place amino acids in the correct order. This makes day to day protein production more accurate and steady.
Through its protein, the LAGE3 gene works with partner proteins in the KEOPS complex, a small cellular team. Together they carry out the transfer RNA change that supports steady protein production.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LAGE3 gene can make its protein unstable or less able to join partner proteins, which lowers an important transfer RNA change (a step cells use to build proteins accurately). In understanding how LAGE3 gene variants affect protein function, a key clue is whether some activity remains. Milder variants may leave partial function, while more severe variants can cause near-complete loss and are often linked to earlier, more pronounced Galloway-Mowat syndrome.
How variants are linked to conditions
Pathogenic variants in the LAGE3 gene are a recognized cause of Galloway-Mowat syndrome, a rare inherited condition that often includes early kidney disease, smaller than expected head size, and developmental delay. Some children also have nephrotic syndrome, feeding problems, or seizures, and the severity can vary. In practice, conditions linked to variants in the LAGE3 gene mainly center on Galloway-Mowat syndrome, and a disease-causing variant can confirm the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found across the general population. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LAGE3 gene. For many living with a LAGE3 change, risk is mainly tied to the genetic change itself rather than everyday lifestyle factors, and personal guidance from a doctor or genetic counselor can help put that risk in context.
Inheritance of LAGE3 variants
LAGE3-related conditions follow an X-linked inheritance pattern. In practical terms, inheritance of the LAGE3 gene variants depends on the fact that the LAGE3 gene is on the X chromosome, so the chances can differ for sons and daughters. A mother carrying a disease-causing variant may pass it to either child, while a father passes his X chromosome only to his daughters. For the well-established LAGE3-related condition, this pattern is treated as X-linked recessive, meaning males are more often affected and females may be carriers.
What does my LAGE3 result mean for my family?
A disease-causing change in the LAGE3 gene is usually passed in an X-linked pattern, so it can have implications for close relatives on the mother’s side of the family. Mothers, sisters, and other female relatives may be carriers, while boys in the family may be more likely to develop the related condition. Which relatives could be affected or carry the change depends on the family’s exact test result.
Genetic information
Genetic testing
How you find out about variants
LAGE3 genetic testing looks for DNA changes in a blood sample or cheek swab, often through exome sequencing, a multigene panel, or targeted testing when a family variant is known. Results may find a relevant variant, find none, or show a variant of uncertain significance, meaning its health effect is still unclear.
When should I consider getting a genetic test?
Testing for changes in the LAGE3 gene may be considered when a child has serious early kidney disease along with poor brain and head growth, developmental delay, or a family history of the same condition. It can also help when a known LAGE3 variant runs in the family, including for relatives considering future pregnancies.
A genetic result is only one part of your health story
Genetic results can provide valuable insight, but how much they explain varies by the condition and the kind of variant involved. Lifestyle, environment, age, and medical history are among the many factors that influence how the body functions over time. For some conditions, especially ones shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, it may also help put a person’s experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the expected benefit while the other may have less effect or be more sensitive to side effects, partly because their bodies break down or handle the drug differently. These inherited differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can affect the way a person responds to medication. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the LAGE3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or whether side effects are more likely, so medication concerns or new symptoms are best discussed with your doctor.
History
LAGE3 entered the medical literature through broader efforts to map and name human genes during the expansion of modern genetics in the 1990s and early 2000s. It was first recognized as part of a gene family with a limited but growing research profile, rather than as a gene already tied to a well-known public story. From these first observations, research expanded steadily. Interest in the LAGE3 gene increased later when studies linked harmful inherited variants to a rare condition affecting kidney function and brain development. That work gave the gene clearer clinical importance and moved it from basic gene cataloging into medical genetics. Today, LAGE3 is mainly known in specialist care and research rather than in public awareness.